Management of pregnancy in antiphospholipid syndrome (Q34354754)

1 August 2017

1 reference

title

Management of pregnancy in antiphospholipid syndrome (English)

1 reference

1 August 2017

3

Khamashta MA

1 reference

1 August 2017

Shehata HA

1

1 reference

PubMed ID

11534266

1 August 2017

Nelson-Piercy C

series ordinal

2

1 reference

1 August 2017

1 August 2001

1 reference

Rheumatic Diseases Clinics of North America

1 August 2017

1 reference

1 August 2017

27

1 reference

1 August 2017

643-659

1 reference

1 August 2017

3

1 reference

The cell biology of human implantation.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibodies in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

A Study of 100 High Risk Lupus Pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Trophoblast migration during human placental implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Prolonged heparin therapy in pregnancy causes bone demineralization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Low-dose aspirin in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Human cytotrophoblast invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Plasma exchange and the anticardiolipin syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Obstetric outcome in antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The trophoblast as an integral component of a macrophage-cytokine network

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Cerebrovascular ischemia associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Early Doppler Studies in Lupus Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Pregnancy-associated osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Adverse pregnancy outcome in the antiphospholipid syndrome: focus for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Anti-phospholipid antibody and pregnancy wastage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Lupus anticoagulant in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Is warfarin sodium contraindicated in the lactating mother?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Human trophoblast invasion. Autocrine control and paracrine modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Heparin-induced osteoporosis in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Maternal and fetal sequelae of anticoagulation during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

May mothers given warfarin breast-feed their infants?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Anti-cardiolipin antibodies and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Recurrent miscarriage: autoimmune considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Variable effects on murine pregnancy of immunoglobulin G fractions from women with antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Osteoporosis of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970226-X

7 January 2021

10.1016/S0889-857X(05)70226-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11534266